Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India

INTRODUCTION: Results of Sofosbuvir based regimens for hepatitis C (HCV) recurrence after liver transplantation are available from well-designed clinical trials. Most of the data is from deceased donor liver transplant (DDLT) setting, and data on “real world” experience for HCV recurrence after livi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Exp Hepatol
Auteurs principaux: Choudhary, Narendra S., Saigal, Sanjiv, Gautam, Dheeraj, Saraf, Neeraj, Rastogi, Amit, Goja, Sanjay, Bhangui, Prashant, Soin, Arvinder S.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992320/
https://ncbi.nlm.nih.gov/pubmed/29892173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.08.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires